HELICOS BIOSCIENCES CORP 8-K 2009
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): April 9, 2009
HELICOS BIOSCIENCES CORPORATION
(Exact Name of Registrant as Specified in Charter)
(Registrants telephone number, including area code)
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425).
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12).
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)).
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)).
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On April 9, 2009, the Compensation Committee of the Board of Directors of Helicos BioSciences Corporation (Helicos or the Company) decided to renew the monthly housing allowance for Stephen P. Hall, Senior Vice President, Chief Financial Officer and Treasurer of Helicos for an additional six month period. Mr. Halls housing allowance is provided in a lump sum payment of $3,000 per month and is treated as a taxable benefit for Mr. Hall. In addition, the Compensation Committee approved the Companys reimbursement of Mr. Halls ongoing commuting expenses to and from the Companys Cambridge, Massachusetts headquarters together with a gross up of such reimbursement for taxes for an additional six month period.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.